Skip to main content


Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4

Fig. 4

TRIP13 induced EMT in HCC cells. a-b The morphology of HCC cells with different TRIP13 expression. c-d Western blot analysis of the EMT markers (E-cadherin, N-cadherin, vimentin) in MHCC97H or SMMC7721 cells with knockdown or overexpressing TRIP13. e IHC staining of EMT markers (E-cadherin, Vimentin, Snail) in serial section of human HCC tissues. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page